Zhaoke Ophthalmology Limited (6622.HK)

Healthcare | Biotechnology
Income Statement (Quarterly) 2026-04-08 2025-06-30 2025-03-31 2024-12-31
Revenue 15,803,000 15,803,000 7,901,500 9,777,500
Cost of Revenue 7,336,000 7,336,000 3,668,000 5,299,000
Gross Profit 8,467,000 8,467,000 4,233,500 4,478,500
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 53,980,000 53,980,000 26,990,000 37,289,500
Operating Expenses 167,030,000 167,030,000 83,515,000 118,474,000
Operating Income -158,563,000 -158,563,000 -79,281,500 -113,995,500
Interest Expense 0 4,340,000 0 0
Income Before Tax -116,623,000 -116,623,000 -58,311,500 -80,845,500
Income Tax Expense 0 0 0 0
Net Income -116,623,000 -116,623,000 -58,311,500 -80,845,500
Per Share
EPS -0.22 -0.22 -0.11 -0.15
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue 69,324,000 18,750,000 0 0 0
Cost of Revenue 17,527,000 4,503,000 0 0 0
Gross Profit 51,797,000 14,247,000 0 0 0
Operating Expenses
R&D Expenses 0 0 0 0 0
SG&A Expenses 134,281,000 43,160,000 48,090,000 65,446,000 16,836,000
Operating Expenses 279,788,000 390,814,000 405,006,000 380,298,000 118,057,000
Operating Income -227,991,000 -376,567,000 -404,175,000 -364,332,000 -118,057,000
Interest Expense 9,502,000 7,921,000 3,142,000 1,949,000 1,655,000
Income Before Tax -237,493,000 -384,488,000 -407,317,000 -2,129,780,000 -726,981,000
Income Tax Expense 0 550,000 3,142,000 0 0
Net Income -237,493,000 -385,038,000 -410,459,000 -2,129,780,000 -726,981,000
Per Share
EPS -0.43 -0.71 -0.76 -3.98 -1.36
EPS Diluted 0.00 0.00 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Cash and Cash Equivalents 1,121,005,000 1,461,623,000 1,716,351,000 2,128,429,000
Short Term Investments 70,156,000 0 8,873,000 8,157,000
Net Receivables 15,353,000 3,710,000 0 0
Inventory 14,901,000 6,141,000 0 0
Total Current Assets 1,614,912,000 1,794,569,000 1,972,747,000 2,208,894,000
Property Plant Equipment 192,137,000 233,306,000 263,253,000 234,130,000
Goodwill and Intangibles 413,553,000 392,463,000 334,623,000 162,383,000
Total Assets 2,243,515,000 2,420,338,000 2,570,623,000 2,605,407,000
Liabilities
Account Payables 1,169,000 1,166,000 11,051,000 0
Short Term Debt 222,538,000 216,162,000 104,225,000 16,171,000
Total Current Liabilities 313,049,000 336,451,000 194,540,000 89,008,000
Long Term Debt 16,049,000 21,864,000 27,703,000 20,861,000
Total Liabilities 343,438,000 372,020,000 222,250,000 109,920,000
Shareholders Equity
Retained Earnings 0 -3,806,856,000 -3,429,275,000 0
Total Shareholders Equity 1,900,077,000 2,048,318,000 2,348,373,000 2,495,487,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Assets
Cash and Cash Equivalents 1,121,005,000 1,461,623,000 1,716,351,000 2,128,429,000 65,096,000
Short Term Investments 70,156,000 0 8,873,000 8,157,000 806,247,000
Net Receivables 15,353,000 3,710,000 0 0 0
Inventory 14,901,000 6,141,000 0 0 0
Total Current Assets 1,614,912,000 1,794,569,000 1,972,747,000 2,208,894,000 913,623,000
Property Plant Equipment 192,137,000 233,306,000 263,253,000 234,130,000 174,272,000
Goodwill and Intangibles 413,553,000 392,463,000 334,623,000 162,383,000 138,691,000
Total Assets 2,243,515,000 2,420,338,000 2,570,623,000 2,605,407,000 1,226,586,000
Liabilities
Account Payables 1,169,000 1,166,000 11,051,000 0 0
Short Term Debt 222,538,000 216,162,000 104,225,000 16,171,000 14,749,000
Total Current Liabilities 313,049,000 336,451,000 194,540,000 89,008,000 53,666,000
Long Term Debt 16,049,000 21,864,000 27,703,000 20,861,000 22,778,000
Total Liabilities 343,438,000 372,020,000 222,250,000 109,920,000 1,972,554,000
Shareholders Equity
Retained Earnings 0 -3,806,856,000 -3,429,275,000 0 -892,178,000
Total Shareholders Equity 1,900,077,000 2,048,318,000 2,348,373,000 2,495,487,000 -745,968,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Activities
Net Income -237,493,000 -384,488,000 -407,317,000 -2,129,780,000
Depreciation & Amortization 53,564,000 48,704,000 35,074,000 25,831,000
Stock Based Compensation 8,665,000 22,023,000 46,684,000 109,858,000
Change in Working Capital -41,690,000 59,352,000 646,000 2,909,000
Operating Cash Flow -253,723,000 -323,664,000 -331,050,000 -245,143,000
Investing Activities
Capital Expenditure -44,070,000 -95,267,000 -238,552,000 -94,492,000
Investments -10,098,000 -36,467,000 -238,552,000 -65,529,000
Investing Cash Flow -116,448,000 -75,768,000 -324,568,000 683,521,000
Financing Activities
Debt Repayment 6,028,000 112,077,000 -9,600,000 -400,000
Common Stock Issued/Repurchased 0 1,853,000 1,250,000 1,743,334,000
Dividends Paid 0 0 0 0
Financing Cash Flow -12,122,000 99,294,000 76,230,000 1,658,515,000
Summary
Free Cash Flow -297,793,000 -418,931,000 -569,602,000 -339,635,000
Net Change in Cash -340,618,000 -254,728,000 -412,078,000 2,063,333,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Operating Activities
Net Income -237,493,000 -384,488,000 -407,317,000 -2,129,780,000 -726,981,000
Depreciation & Amortization 53,564,000 48,704,000 35,074,000 25,831,000 19,853,000
Stock Based Compensation 8,665,000 22,023,000 46,684,000 109,858,000 14,998,000
Change in Working Capital -41,690,000 59,352,000 646,000 2,909,000 -19,007,000
Operating Cash Flow -253,723,000 -323,664,000 -331,050,000 -245,143,000 -103,425,000
Investing Activities
Capital Expenditure -44,070,000 -95,267,000 -238,552,000 -94,492,000 -175,955,000
Investments -10,098,000 -36,467,000 -238,552,000 -65,529,000 -66,360,000
Investing Cash Flow -116,448,000 -75,768,000 -324,568,000 683,521,000 -955,483,000
Financing Activities
Debt Repayment 6,028,000 112,077,000 -9,600,000 -400,000 0
Common Stock Issued/Repurchased 0 1,853,000 1,250,000 1,743,334,000 0
Dividends Paid 0 0 0 0 0
Financing Cash Flow -12,122,000 99,294,000 76,230,000 1,658,515,000 973,687,000
Summary
Free Cash Flow -297,793,000 -418,931,000 -569,602,000 -339,635,000 -279,380,000
Net Change in Cash -340,618,000 -254,728,000 -412,078,000 2,063,333,000 -89,673,000